Invention Grant
- Patent Title: FSH receptor antagonists
- Patent Title (中): FSH受体拮抗剂
-
Application No.: US14346203Application Date: 2012-09-14
-
Publication No.: US09127007B2Publication Date: 2015-09-08
- Inventor: Wesley Peter Blackaby , Martin De Kort , Mark Enthoven , Paul Stuart Hinchliffe , Christian Bernard Matthijs Poulie , Cornelis Marius Timmers , Saskia Verkaik
- Applicant: Wesley Peter Blackaby , Martin De Kort , Mark Enthoven , Paul Stuart Hinchliffe , Christian Bernard Matthijs Poulie , Cornelis Marius Timmers , Saskia Verkaik
- Applicant Address: NL BN Haarlem
- Assignee: Merck Sharp & Dohme B.V.
- Current Assignee: Merck Sharp & Dohme B.V.
- Current Assignee Address: NL BN Haarlem
- Agent Anna L. Cocuzzo; Catherine D. Fitch
- Priority: EP11182306 20110922
- International Application: PCT/EP2012/068080 WO 20120914
- International Announcement: WO2013/041458 WO 20130328
- Main IPC: C07D471/14
- IPC: C07D471/14 ; A61K31/4745 ; A61K31/4375 ; C07D471/04
Abstract:
The invention relates to FSH receptor antagonist according to general formula (I) or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.
Public/Granted literature
- US20140350043A1 FSH RECEPTOR ANTAGONISTS Public/Granted day:2014-11-27
Information query
